BIMI International Medical (BIMI) Ratios

230 Followers

BIMI International Medical Ratios

BIMI's free cash flow for Q2 2023 was $0.52. For the 2023 fiscal year, BIMI's free cash flow was decreased by $ and operating cash flow was $0.22. See a summary of the company’s cash flow.

Ratios	TTM	Dec 22	Mar 22	Mar 21	Mar 20
Liquidity Ratios
Current Ratio	―	0.92	0.96	1.62	1.02
Quick Ratio	―	0.61	0.72	1.57	0.99
Cash Ratio	―	0.09	0.22	<0.01	<0.01
Solvency Ratio	―	-0.73	-1.30	-0.32	-0.19
Operating Cash Flow Ratio	―	-0.40	-0.06	-0.23	-0.10
Short-Term Operating Cash Flow Coverage	―	-5.04	-0.20	-0.82	-19.23
Net Current Asset Value	$ ―	$ -7.26M	$ -5.63M	$ 8.88M	$ 500.76K
Leverage Ratios
Debt-to-Assets Ratio	―	0.15	0.23	0.15	<0.01
Debt-to-Equity Ratio	―	1.35	0.78	0.30	0.01
Debt-to-Capital Ratio	―	0.57	0.44	0.23	0.01
Long-Term Debt-to-Capital Ratio	―	0.07	0.05	0.04	0.00
Financial Leverage Ratio	―	8.82	3.41	1.99	3.46
Debt Service Coverage Ratio	―	-3.29	-3.64	-0.84	-11.15
Interest Coverage Ratio	―	-4.47	-3.32	-44.89	-155.35
Debt to Market Cap	―	7.16	5.04	2.81	0.04
Interest Debt Per Share	―	3.33	20.84	23.98	0.70
Net Debt to EBITDA	―	-0.17	-0.12	-1.53	-0.06
Profitability Margins
Gross Profit Margin	―	16.48%	11.38%	19.02%	-92.42%
EBIT Margin	―	-153.77%	-151.13%	-25.43%	-968.49%
EBITDA Margin	―	-151.88%	-149.99%	-25.00%	-802.65%
Operating Profit Margin	―	-129.65%	-38.03%	-29.68%	-624.14%
Pretax Profit Margin	―	-182.77%	-162.59%	-26.10%	-972.29%
Net Profit Margin	―	-189.29%	-164.10%	-41.21%	-2809.88%
Continuous Operations Profit Margin	―	-182.82%	-162.73%	-29.47%	-972.29%
Net Income Per EBT	―	103.57%	100.93%	157.92%	289.00%
EBT Per EBIT	―	140.97%	427.58%	87.93%	155.78%
Return on Assets (ROA)	―	-62.70%	-91.76%	-15.94%	-14.77%
Return on Equity (ROE)	―	-553.23%	-312.56%	-31.68%	-51.13%
Return on Capital Employed (ROCE)	―	-148.16%	-50.55%	-21.61%	-11.58%
Return on Invested Capital (ROIC)	―	-118.73%	-35.51%	-17.39%	-11.44%
Return on Tangible Assets	―	-66.58%	-117.66%	-20.14%	-20.10%
Earnings Yield	―	-6831.40%	-2558.30%	-296.99%	-170.34%
Efficiency Ratios
Receivables Turnover	―	2.83	3.51	1.54	15.65
Payables Turnover	―	0.92	3.63	1.78	0.00
Inventory Turnover	―	1.29	3.67	14.15	0.43
Fixed Asset Turnover	―	2.55	2.55	14.11	4.09
Asset Turnover	―	0.33	0.56	0.39	<0.01
Working Capital Turnover Ratio	―	-7.73	4.91	2.54	-0.03
Cash Conversion Cycle	―	13.14	102.93	57.43	872.49
Days of Sales Outstanding	―	128.82	103.99	236.97	23.32
Days of Inventory Outstanding	―	282.77	99.45	25.80	849.16
Days of Payables Outstanding	―	398.45	100.51	205.34	0.00
Operating Cycle	―	411.59	203.44	262.78	872.49
Cash Flow Ratios
Operating Cash Flow Per Share	―	-3.85	-2.38	-16.48	-12.64
Free Cash Flow Per Share	―	-3.85	-3.90	-17.69	-12.64
CapEx Per Share	―	0.00	1.52	1.21	0.00
Free Cash Flow to Operating Cash Flow	―	1.00	1.64	1.07	1.00
Dividend Paid and CapEx Coverage Ratio	―	0.00	-1.57	-13.58	0.00
Capital Expenditure Coverage Ratio	―	0.00	-1.57	-13.58	0.00
Operating Cash Flow Coverage Ratio	―	-1.88	-0.15	-0.70	-19.23
Operating Cash Flow to Sales Ratio	―	-0.87	-0.06	-0.27	-13.07
Free Cash Flow Yield	―	-3128.54%	-152.86%	-211.89%	-79.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-0.01	-0.04	-0.34	-0.59
Price-to-Sales (P/S) Ratio	―	0.03	0.06	0.14	16.50
Price-to-Book (P/B) Ratio	―	0.08	0.12	0.11	0.30
Price-to-Free Cash Flow (P/FCF) Ratio	―	-0.03	-0.65	-0.47	-1.26
Price-to-Operating Cash Flow Ratio	―	-0.03	-1.07	-0.51	-1.26
Price-to-Earnings Growth (PEG) Ratio	―	<0.01	>-0.01	0.03	<0.01
Price-to-Fair Value	―	0.08	0.12	0.11	0.30
Enterprise Value Multiple	―	-0.19	-0.17	-2.08	-2.11
Enterprise Value	―	3.45M	5.30M	6.68M	2.68M
EV to EBITDA	―	-0.19	-0.17	-2.08	-2.11
EV to Sales	―	0.29	0.25	0.52	16.95
EV to Free Cash Flow	―	-0.34	-2.54	-1.77	-1.30
EV to Operating Cash Flow	―	-0.34	-4.16	-1.90	-1.30
Tangible Book Value Per Share	―	1.18	5.49	46.75	3.30
Shareholders’ Equity Per Share	―	1.52	20.87	78.29	53.14
Tax and Other Ratios
Effective Tax Rate	―	>-0.01	>-0.01	-0.13	0.00
Revenue Per Share	―	4.44	39.75	60.18	0.97
Net Income Per Share	―	-8.40	-65.24	-24.80	-27.17
Tax Burden	―	1.04	1.01	1.58	2.89
Interest Burden	―	1.19	1.08	1.03	1.00
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	0.90	0.28	0.43	6.24
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	0.46	0.04	0.93	0.91

Currency in USD